The US Food and Drug Administration on Thursday halted the emergency use authorization of Evusheld because it does not appear to protect against Covid-19 from viral variants currently circulating in the United States.Evusheld is a monoclonal antibody therapy used to prevent Covid-19 in immunocompromised people, who are less likely to generate an immune response from Covid-19 vaccination.
#people #information #united-states #coronavirus #vaccination #disease-control #astrazeneca #authorization
[
add
]
[
|
|
...
]